New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice

被引:82
作者
Hashimoto, Hitoshi [1 ]
Shintani, Norihito [1 ]
Baba, Akemichi [1 ]
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka 5650871, Japan
来源
VIP, PACAP, AND RELATED PEPTIDES: FROM GENE TO THERAPY | 2006年 / 1070卷
关键词
Adcyapl; animal model; knockout mouse; neuropeptide; PACAP;
D O I
10.1196/annals.1317.038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a structurally highly conserved neuropeptide and displays pleiotropic activity, including functioning as a neurotransmitter, neuromodulator, and neurotrophic factor. A series of recent experiments, including genetic manipulation of PACAP and its receptors, has led to better understanding of both normal and pathological processes in which PACAP has been proposed to play a role, and sheds light on previously uncharacterized functions of endogenous PACAP, The aim of this article is to briefly review the recent advances in understanding the role of PACAP in the central nervous system from PACAP- and PACAP receptor-deficient mice, particularly with respect to behavioral and neurological features, including psychomotor behavior, feeding, stress responses, memory performance, ethanol sensitivity, chronic pain, and circadian rhythms. This article also discusses their potential involvement in human diseases.
引用
收藏
页码:75 / 89
页数:15
相关论文
共 77 条
[21]   Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis [J].
Hamelink, C ;
Tjurmina, O ;
Damadzic, R ;
Young, WS ;
Weihe, E ;
Lee, HW ;
Eiden, LE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :461-466
[22]  
Hannibal J, 2000, J COMP NEUROL, V418, P147
[23]   The photopigment melanopsin is exclusively present in pituitary adenylate cyclase-activating polypeptide-containing retinal ganglion cells of the retinohypothalamic tract [J].
Hannibal, J ;
Hindersson, P ;
Knudsen, SM ;
Georg, B ;
Fahrenkrug, J .
JOURNAL OF NEUROSCIENCE, 2002, 22 (01)
[24]   Neurotransmitters of the retino-hypothalamic tract [J].
Hannibal, J .
CELL AND TISSUE RESEARCH, 2002, 309 (01) :73-88
[25]   Dissociation between light-induced phase shift of the circadian rhythm and clock gene expression in mice lacking the pituitary adenylate cyclase activating polypeptide type 1 receptor [J].
Hannibal, J ;
Jamen, F ;
Nielsen, HS ;
Journot, L ;
Brabet, P ;
Fahrenkrug, J .
JOURNAL OF NEUROSCIENCE, 2001, 21 (13) :4883-4890
[26]   Pituitary adenylate cyclase-activating peptide in the rat central nervous system: An immunohistochemical and in situ hybridization study [J].
Hannibal, J .
JOURNAL OF COMPARATIVE NEUROLOGY, 2002, 453 (04) :389-417
[27]   An essential role for peptidergic signalling in the control of circadian rhythms in the suprachiasmatic nuclei [J].
Harmar, AJ .
JOURNAL OF NEUROENDOCRINOLOGY, 2003, 15 (04) :335-338
[28]   The VPAC2 receptor is essential for circadian function in the mouse suprachiasmatic nuclei [J].
Harmar, AJ ;
Marston, HM ;
Shen, SB ;
Spratt, C ;
West, KM ;
Sheward, WJ ;
Morrison, CF ;
Dorin, JR ;
Piggins, HD ;
Reubi, JC ;
Kelly, JS ;
Maywood, ES ;
Hastings, MH .
CELL, 2002, 109 (04) :497-508
[29]  
Harmar AJ, 1998, PHARMACOL REV, V50, P265
[30]   Mice with markedly reduced PACAP (PAC1) receptor expression by targeted deletion of the signal peptide [J].
Hashimoto, H ;
Shintani, N ;
Nishino, A ;
Okabe, M ;
Ikawa, M ;
Matsuyama, S ;
Itoh, K ;
Yamamoto, K ;
Tomimoto, S ;
Fujita, T ;
Hagihara, N ;
Mori, W ;
Koyama, Y ;
Matsuda, T ;
Nagata, S ;
Baba, A .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (05) :1810-1817